Boston Scientific Corporation (BSX-PA)

Select a metric from the list below to chart it

Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Revenue
7,143.0
7,380.0
7,477.0
8,386.0
9,048.0
9,823.0
10,735.0
9,913.0
11,888.0
12,682.0
Revenue % Chg.
-1.5%
3.3%
1.3%
12.2%
7.9%
8.6%
9.3%
-7.7%
19.9%
6.7%
Cost of Revenue
2,314.0
2,321.0
2,243.0
2,503.0
2,661.0
2,883.0
3,181.0
3,510.0
3,760.0
4,003.0
Cost of Revenue % Chg.
-7.5%
0.3%
-3.4%
11.6%
6.3%
8.3%
10.3%
10.3%
7.1%
6.5%
Gross Profit
4,829.0
5,059.0
5,234.0
5,883.0
6,387.0
6,940.0
7,554.0
6,403.0
8,128.0
8,679.0
Gross Profit % Chg.
1.7%
4.8%
3.5%
12.4%
8.6%
8.7%
8.8%
-15.2%
26.9%
6.8%
Gross Profit Margin
67.6%
68.6%
70.0%
70.2%
70.6%
70.7%
70.4%
64.6%
68.4%
68.4%
Gross Profit Margin % Chg.
3.2%
1.4%
2.1%
0.2%
0.6%
0.1%
-0.4%
-8.2%
5.9%
0.1%
R&D Expenses
861.0
817.0
876.0
920.0
997.0
1,113.0
1,174.0
1,143.0
1,204.0
1,323.0
R&D Expenses % Chg.
-2.8%
-5.1%
7.2%
5.0%
8.4%
11.6%
5.5%
-2.6%
5.3%
9.9%
Selling, General, & Admin Expenses
2,674.0
2,902.0
2,873.0
3,099.0
3,294.0
3,569.0
3,941.0
3,787.0
4,359.0
4,520.0
Selling, General, & Admin Expenses % Chg.
5.5%
8.5%
-1.0%
7.9%
6.3%
8.3%
10.4%
-3.9%
15.1%
3.7%
Other Expenses
410.0
438.0
495.0
545.0
565.0
599.0
699.0
789.0
741.0
803.0
Other Expenses % Chg.
3.8%
6.8%
13.0%
10.1%
3.7%
6.0%
16.7%
12.9%
-6.1%
8.4%
Operating Income
120.0
-301.0
-327.0
447.0
1,285.0
1,506.0
1,518.0
-80.0
1,199.0
2,033.0
Operating Income % Chg.
8.6%
187.5%
17.2%
0.8%
69.6%
Operating Income Margin
1.7%
-4.1%
-4.4%
5.3%
14.2%
15.3%
14.1%
-0.8%
10.1%
16.0%
Operating Income Margin % Chg.
7.2%
166.4%
8.0%
-7.8%
58.9%
Total Other Income/Expenses Net
-343.0
-208.0
-323.0
-270.0
-352.0
-84.0
-831.0
1.0
-123.0
-892.0
Total Other Income/Expenses Net % Chg.
43.5%
39.4%
55.3%
16.4%
30.4%
76.1%
889.3%
625.2%
Income Before Tax
-223.0
-509.0
-650.0
177.0
933.0
1,422.0
687.0
-79.0
1,076.0
1,141.0
Income Before Tax % Chg.
94.6%
128.3%
27.7%
427.1%
52.4%
-51.7%
6.0%
Income Before Tax Margin
-3.1%
-6.9%
-8.7%
2.1%
10.3%
14.5%
6.4%
-0.8%
9.1%
9.0%
Income Before Tax Margin % Chg.
94.5%
120.9%
26.0%
388.6%
40.4%
-55.8%
-0.6%
Income Tax Expense
-102.0
-390.0
-411.0
-170.0
828.0
-249.0
-4,013.0
2.0
36.0
443.0
Income Tax Expense % Chg.
161.5%
282.4%
5.4%
58.6%
1511.6%
1700.0%
1130.6%
Net Income
-121.0
-119.0
-239.0
347.0
104.0
1,671.0
4,700.0
-82.0
1,041.0
698.0
Net Income % Chg.
97.0%
1.7%
100.8%
-70.0%
1506.7%
181.3%
-32.9%
Net Income Margin
-1.7%
-1.6%
-3.2%
4.1%
1.1%
17.0%
43.8%
-0.8%
8.8%
5.5%
Net Income Margin % Chg.
97.0%
4.8%
98.2%
-72.2%
1380.0%
157.4%
-37.1%
EPS
0.5
EPS Diluted
0.5
Interest Income
6.0
5.0
5.0
5.0
5.0
3.0
30.0
3.0
4.0
10.0
Interest Income % Chg.
20.0%
-16.7%
-40.0%
900.0%
-90.0%
33.3%
150.0%
Interest Expense
324.0
216.0
284.0
233.0
229.0
241.0
473.0
361.0
341.0
470.0
Interest Expense % Chg.
24.1%
-33.3%
31.5%
-18.0%
-1.7%
5.2%
96.3%
-23.7%
-5.5%
37.8%
EBIT
-541.0
-720.0
-929.0
-51.0
709.0
1,184.0
244.0
-437.0
739.0
681.0
EBIT % Chg.
87.6%
33.1%
29.0%
94.5%
67.0%
-79.4%
-7.8%
EBIT Margin
-7.6%
-9.8%
-12.4%
-0.6%
7.8%
12.1%
2.3%
-4.4%
6.2%
5.4%
EBIT Margin % Chg.
87.4%
28.8%
27.4%
95.1%
53.8%
-81.1%
-13.6%
Depreciation & Amortization
689.0
725.0
769.0
815.0
844.0
894.0
1,011.0
1,123.0
1,093.0
1,136.0
Depreciation & Amortization % Chg.
0.9%
5.2%
6.1%
6.0%
3.6%
5.9%
13.1%
11.1%
-2.7%
3.9%
EBITDA
148.0
5.0
-160.0
764.0
1,553.0
2,078.0
1,255.0
686.0
1,832.0
1,817.0
EBITDA % Chg.
-96.6%
103.3%
33.8%
-39.6%
-45.3%
167.1%
-0.8%
EBITDA Margin
2.1%
0.1%
-2.1%
9.1%
17.2%
21.2%
11.7%
6.9%
15.4%
14.3%
EBITDA Margin % Chg.
-96.7%
88.4%
23.2%
-44.7%
-40.8%
122.7%
-7.0%